Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Bluegreen who wrote (9753)	5/2/1999 11:03:00 AM
From: aknahow	Read Replies (1) \| Respond to of 17367

Proxies are now being received. Please mark your proxy against management on all proposals and mail it back. Many shareholders simply throw the proxies away. Rather than simply not vote, please vote this time. We will have a chance to see how many votes against management can be mobilized by post on S.I. and Yahoo. Why vote against management? Did you like being kept in the dark about the pre established mortality requirement? Do you like not having any idea what was said by Dr. Scannon on his clinical updates, such as the Superbug Super Drug conference in London? Do you like not having any idea of what Castello said at the San Diego Sutro meeting? The Biocentury meeting? Do you like floorless convertibles? You may think voting against management will do no good. Perhaps you are correct but try it out.

To: Bluegreen who wrote (9753)	5/2/1999 11:36:00 AM
From: Bluegreen	Respond to of 17367

SL, I totally disagree! If Meningo. fails, I don't think GNE will let morale and stock price get as low as you proclaim. There might be a chance for a short period of time to pick up shares at ultra low prices but once again in my opinion GNE is Xoma's angel while their baby is in phase III in conjunction with Xoma. GNE has NOT been afraid to own Xoma shares in the past. A dollar a share would put Xoma market cap around 50 million. You only need 51% of that to take control. In my opinion, I think 3 dollars a share is a bargain for just the chance of antipsoriasis drug going to market, let alone possible antimicrobial drug to market. Hey SL, I hear that Xoma is anticipating the POSSIBLE of approval of an antimicrobial drug called Neuprex!!<g> Now what has Xoma done in way of that anticipation? You sold half your shares but Jack Castello hasn't and more to the point George and I have bought shares recently! But as they say, that is what makes a market. I know I have complained about the mortality requirement BUT it has allowed me more time to buy more at these levels. Only my opinions, I could be totally wrong.